Adrenal insufficiency: identification and management

Equality impact assessment - Final (PDF 245 KB)

Committee member list (PDF 141 KB)

Consultation comments and responses (PDF 1.36 MB)

Draft guidance consultation

Draft guideline (PDF version) (PDF 625 KB)

Evidence review A - Information and Support (PDF 692 KB)

Evidence review B - When to suspect Adrenal Insufficiency (PDF 4.04 MB)

Evidence review C - When to Refer For Steroid Withdrawal (PDF 895 KB)

Evidence review D - Diagnostic Tests and Thresholds for Referral (PDF 1.24 MB)

Evidence review E - Methods for Corticosteroid Withdrawal (PDF 876 KB)

Evidence review F - Routine Pharma PrimaryAI (PDF 2.07 MB)

Evidence review G - Routine Pharma SecondaryAI TertiaryAI (PDF 3.81 MB)

Evidence review H - When to Suspect Adrenal Crisis (PDF 751 KB)

Evidence review I - Emergency Management Adrenal Crisis (PDF 651 KB)

Evidence review J - Pharma Management Physiological Stress (PDF 925 KB)

Evidence review K - Pharma Management Psychological Stress (PDF 455 KB)

Evidence review L - NonPharma Management Physiological Stress (PDF 394 KB)

Evidence review M - NonPharma Management Psychological Stress (PDF 393 KB)

Evidence review N - Ongoing care Monitoring including end of life care (PDF 387 KB)

Supporting documentation - Methods chapter (PDF 1.08 MB)

Supporting documentation - Rationale for drug doses (PDF 187 KB)

Comments form (MSWord 49 KB)

Review questions (PDF 119 KB)

Call for evidence

Comments form (MSWord 71 KB)

Committee meeting

Minutes 1 (PDF 206 KB)

Minutes 2 (PDF 191 KB)

Minutes 3 (PDF 233 KB)

Minutes 4 (PDF 216 KB)

Minutes 5 (PDF 214 KB)

Minutes 6 (PDF 213 KB)

Minutes 7 (PDF 203 KB)

Minutes 8 (PDF 192 KB)

Minutes 9 (PDF 230 KB)

Minutes 10 (PDF 205 KB)

Minutes 11 (PDF 209 KB)

Minutes 12 (PDF 204 KB)

Minutes 13 (PDF 194 KB)

Final scope (PDF 329 KB)

Consultation comments and responses (PDF 358 KB)

Draft scope consultation

Draft scope (PDF 334 KB)

Equality impact assessment 1 (PDF 153 KB)

Workshop notes Group 2  (PDF 222 KB)